Gsk Plc-spon Adr. share price logo

Gsk Plc-spon Adr. Share Price

NYSE: GSK

Large Cap

$46.63

-0.47

(-0.99%)

as on

Gsk Plc-spon Adr. Stock Performance

as on November 8, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $46.38
    $46.93
    downward going graph

    0.54%

    Downside

    0.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $31.72
    $47.21
    downward going graph

    31.99%

    Downside

    1.23%

    Upside

    downward going graph

Gsk Plc-spon Adr. share price movements today

Previous Close
$47.10
Open
$46.70
Volume
5.4M
Day's Low - High
$46.38 - $46.93
52 Week Low - High
$31.72 - $47.21

Gsk Plc-spon Adr. Historical Returns

1 Month Return
+ 8.28 %
3 Month Return
+ 25.33 %
1 Year Return
+ 28.48 %
3 Year Return
+ 47.46 %
5 Year Return
+ 2.28 %

Gsk Plc-spon Adr. Stock Fundamentals & Key Indicators

Check Gsk Plc-spon Adr. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$94.5B

EPS (TTM)

4.4838

Dividend Yield

3.45%

Quarterly Earnings Growth YOY

0.23%

PE Ratio (TTM)

13.49

Industry PE ratio

24.098333333333333

PEG Ratio

0.3819

EBITDA

9.5B

Revenue (TTM)

32.2B

Profit Margin

17.08%

Return On Equity TTM

41.52%

Gsk Plc-spon Adr. Stock Valuation

Track how Gsk Plc-spon Adr. P/E has moved over time to understand its valuation trends.

Gsk Plc-spon Adr. in the last 5 years

  • Overview

  • Trends

Lowest (8.78x)

March 31, 2025

Today (13.49x)

November 7, 2025

Industry (24.10x)

November 7, 2025

Highest (13.53x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 13.49x

Gsk Plc-spon Adr. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gsk Plc-spon Adr. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$94.5B2.28%13.4917.08%
BUY$828.6B556.75%45.3830.99%
BUY$383.1B135.91%164.224.00%
BUY$448.1B31.44%17.9727.26%
BUY$210.8B6.74%11.1629.63%

Stock Returns calculator for Gsk Plc-spon Adr. Stock including INR - Dollar returns

The Gsk Plc-spon Adr. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gsk Plc-spon Adr. investment value today

Current value as on today

₹1,32,303

Returns

₹32,303

(+32.3%)

Returns from Gsk Plc-spon Adr. Stock

₹27,196 (+27.2%)

Dollar Returns*

₹5,107 (+5.11%)

Analyst Recommendation on Gsk Plc-spon Adr. Stock

Based on 33 analysts

BUY

60.61%

Buy

30.30%

Hold

9.09%

Sell

Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for Gsk Plc-spon Adr.. Average target price of $47.11

Gsk Plc-spon Adr. Share Price Target

Get share price movements and forecasts by analysts on Gsk Plc-spon Adr..

What analysts predicted

1.02%UPSIDE

Target Price

$47.11

Current Price

$46.63

Analyzed by

33 Analysts

Target

$47.11

Gsk Plc-spon Adr. target price $47.11, a slight upside of 1.02% compared to current price of $46.63. According to 33 analysts rating.

Gsk Plc-spon Adr. Stock’s Investor Sentiment and Interest

Search interest for Gsk Plc-spon Adr. Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Gsk Plc-spon Adr. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
9,064
10,111
10,193
9,358
10,020
10,581
10,262
9,698
7,986
273,619
Gross Profit
6,624
7,291
7,132
6,854
7,323
7,415
7,026
7,199
5,821
95,069
Operating Income
2,141
1,949
573
1,490
1,646
189
696
2,216
2,023
17,828
EBITDA
2,624
2,552
1,157
2,070
2,308
1,171
1,119
3,093
3,230
11,751
Interest Expense
185
182
275
166
174
156
144
162
184
150
Depreciation
452
579
623
549
639
951
412
823
1,159
-
Income Before Tax
1,987
1,791
379
1,355
1,495
64
563
2,108
1,887
17,829
Income Tax Expense
242
257
-19
274
191
-1
62
336
241
6,223
Net Income
2,050
1,816
443
1,329
1,490
-76
523
2,095
1,443
11,606
Net Profit Margin
22.62%
17.97%
4.35%
14.21%
14.88%
-0.72%
5.10%
21.61%
18.07%
4.24%

Gsk Plc-spon Adr. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
35,875
34,795
40,461
39,032
44,193
32,713
32,855
35,696
38,395
39,667
Gross Profit
22,599
23,204
26,599
26,062
28,661
22,063
21,995
24,066
27,551
28,228
Operating Income
10,322
2,598
4,087
5,483
6,961
5,979
4,357
6,433
6,745
4,021
EBITDA
12,891
4,430
6,184
7,350
9,220
8,067
6,485
8,601
9,083
6,668
Interest Expense
757
736
734
743
912
892
784
855
775
657
Depreciation
-
-
1,922
1,856
2,334
2,351
2,524
2,298
1,527
2,551
Income Before Tax
10,526
1,939
3,525
4,800
6,221
5,170
3,599
5,628
6,064
3,477
Income Tax Expense
2,154
877
1,356
754
953
67
83
707
756
526
Net Income
12,629
1,137
2,053
4,588
6,081
7,722
5,833
18,206
6,238
3,255
Net Profit Margin
35.20%
3.27%
5.08%
11.75%
13.76%
23.61%
17.76%
51.00%
16.25%
8.21%

Gsk Plc-spon Adr. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
1,534
350
1,046
1,173
-58
501
1,772
1,646
80
Operating Cash Flow
2,212
2,971
939
882
2,154
2,329
1,145
2,096
520
Investing Cash Flow
-491
207
-201
731
-731
-1,119
-1,144
-625
-
Financing Cash Flow
-1,762
-3,306
-989
-1,314
-1,240
-842
858
-2,372
-
Change in Cash
-18
-241
-146
172
149
375
848
-927
441

Gsk Plc-spon Adr. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
1,062
2,169
4,046
5,268
6,388
5,096
4,921
4,928
2,951
Operating Cash Flow
6,497
6,918
8,421
8,020
8,441
7,952
7,403
6,768
6,554
Investing Cash Flow
-1,269
-1,443
-1,553
-5,354
2,161
-1,777
-8,772
-1,595
-1,229
Financing Cash Flow
-6,392
-6,380
-6,389
-1,840
-10,132
-7,589
823
-5,641
-4,726
Change in Cash
-881
-1,005
487
744
431
-1,443
-394
-567
545

Global Institutional Holdings in Gsk Plc-spon Adr.

Funds
Holdings
Dodge & Cox
3.86%
FMR Inc
2.99%
Fisher Asset Management, LLC
1.54%
PRIMECAP Management Company
1.36%
JTC Employer Solutions Trustee Ltd
0.73%

Gsk Plc-spon Adr. News & Key Events

  • img

    Today's Timeline - 29 October

    Wed, 12:42 PM

    -

    GSK raises 2025 forecasts after strong Q3 results, driven by specialty HIV and cancer drug sales.

    Wed, 02:58 PM

    -

    GSK reports Q3 net profit of £2.01bn, raising 2025 guidance for revenue and adjusted EPS growth.

    Wed, 06:38 PM

    -

    GSK's Q3 sales reach £8.5 billion, exceeding estimates, with strong performance in Specialty Medicines.

  • img

    Today's Timeline - 29 October

    Thu, 07:02 AM

    -

    Jefferies initiates coverage on GSK with a Buy rating, citing growth pipeline and efficiency prospects.

Insights on Gsk Plc-spon Adr.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    GSK Plc's Sponsored ADR has shown strong revenue growth over the last three quarters. Revenue increased from $7.51 billion to $273.61 billion, with an average rise of 51.5% each quarter.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Gsk Plc-spon Adr has shown strong performance in its net profit over the last two quarters. The net profit rose significantly from $1.44 billion to $11.60 billion, averaging an increase of 87.6% each quarter.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GSK has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, GSK stock has moved up by 8.3%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GSK has outperformed top 5 stocks with highest market-cap in its industry

About Gsk Plc-spon Adr.

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
OrganisationGsk Plc-spon Adr.
Headquarters79 New Oxford Street, London, United Kingdom, WC1A 1DG
IndustryHealth Technology
CEOMs. Emma Natasha Walmsley
E-voting on sharesClick here to vote

Key Management of Gsk Plc-spon Adr.

Name

Title

Ms. Julie Belita Brown A.C.A.

CFO & Executive Director

Dr. Jesse L. Goodman M.D., M.P.H.

Scientific & Medical Expert

Ms. Shobie Ramakrishnan

Chief Digital & Technology Officer

Mr. James Ford

Senior VP & Group General Counsel of Legal & Compliance

Ms. Sally Jackson

Senior VP of Global Communications & CEO Office

Mr. David Simon Redfern BSc (Hons), CA

President of Corporate Development

Ms. Diana Conrad

Chief People Officer

Ms. Emma Natasha Walmsley

CEO & Director

Mr. Tony Wood

Chief Scientific Officer and Head of R&D

Mr. Constantin Fest

Senior VP & Head of Investor Relations

FAQs

What is Gsk Plc-spon Adr. share price today?

Gsk Plc-spon Adr. share price today is $46.63 as on at the close of the market. Gsk Plc-spon Adr. share today touched a day high of $46.93 and a low of $46.38.

What is the 52 week high and 52 week low for Gsk Plc-spon Adr. share?

Gsk Plc-spon Adr. share touched a 52 week high of $47.21 on and a 52 week low of $31.72 on . Gsk Plc-spon Adr. stock price today i.e. is closed at $46.63,which is 1.22% down from its 52 week high and 47.03% up from its 52 week low.

What is Gsk Plc-spon Adr.'s market capitalisation today?

Gsk Plc-spon Adr. market capitalisation is $0.09T as on .

How to invest in Gsk Plc-spon Adr. Stock (GSK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gsk Plc-spon Adr. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gsk Plc-spon Adr. Shares that will get you 0.0322 shares as per Gsk Plc-spon Adr. share price of $46.63 per share as on November 8, 2025 at 2:29 am IST.

What is the minimum amount required to buy Gsk Plc-spon Adr. Stock (GSK) from India?

Indian investors can start investing in Gsk Plc-spon Adr. (GSK) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Gsk Plc-spon Adr. stock (as per the Rupee-Dollar exchange rate as on ). Based on Gsk Plc-spon Adr. share’s latest price of $46.63 as on November 8, 2025 at 2:29 am IST, you will get 0.2145 shares of Gsk Plc-spon Adr.. Learn more about fractional shares .

What are the returns that Gsk Plc-spon Adr. has given to Indian investors in the last 5 years?

Gsk Plc-spon Adr. stock has given 2.28% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?